EVALUATION OF A POROUS TANTALUM CRUCIATE-RETAINING HI-FLEX UNCEMENTED MONOBLOCK TIBIAL COMPONENT IN MIS PRIMARY TOTAL KNEE ARTHROPLASTY. CLINICAL AND RADIOLOGICAL RESULTS OF 108 KNEES

Abstract

The purpose of this study was to evaluate a high flex porous tantalum metal monoblock component system implanted through a MIS technique.

A fellowship trained surgeon proficient in MIS surgery performed 109 consecutive TKAs in 95 patients. Patients were implanted with a tantalum monoblock tibia and a fiber-metal cruciate-retaining high flex femur through a MIS midvastus approach. Ninety uncemented porous tantulum monoblock patellae and 19 cemented all polyethylene patellae were implanted.

Knee Society scores and Knee Society radiographic scores were calculated in all patients. Follow-up for a minimum of 2 years was performed in 109 knees. The average follow up was 39 months. Sixty-six percent of the patients were female and 34% male. The average age was 66 years. The average preoperative Knee Society Knee score was 36. The average preop Knee Society Functional Score was 46. Osteoarthritis was the primary diagnosis in 104 knees. Rheumatoid arthritis and Hemophilia was the diagnosis in two knees each.

The average Knee Society Knee Score improved to 89. The average Knee Society Function score improved to 86. 106 of the knees were rated good or excellent and three knees were rated poor. Two patellar revisions were performed for loose components and one for patellar misalignment. One patella fracture occurred that required ORIF. One femoral component was revised for loosening. There were nonprogressive radiographic lucencies demonstrated on 4 tibial components. One tibial component was rated loose. There were radiographic lucencies on 5 femoral components, all nonprogressive. There were two uncemented tantalum patellar components with stable radiolucencies.

Early results in 109 consecutive porous tantalum metal tibial and high flex cruciate-retaining femoral components implanted through an MIS midvastus approach have a high rate of success at a minimum followup of two years.